Emmanuel Vidor

998 total citations
29 papers, 563 citations indexed

About

Emmanuel Vidor is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Emmanuel Vidor has authored 29 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 15 papers in Microbiology and 10 papers in Infectious Diseases. Recurrent topics in Emmanuel Vidor's work include Bacterial Infections and Vaccines (15 papers), Pneumonia and Respiratory Infections (10 papers) and Viral Infections and Immunology Research (9 papers). Emmanuel Vidor is often cited by papers focused on Bacterial Infections and Vaccines (15 papers), Pneumonia and Respiratory Infections (10 papers) and Viral Infections and Immunology Research (9 papers). Emmanuel Vidor collaborates with scholars based in France, United States and China. Emmanuel Vidor's co-authors include Stanley A. Plotkin, Mark A. Fletcher, Agnès Hoffenbach, Marie-Claude Bonnet, Carlton Meschievitz, B. Soubeyrand, Robert S. Daum, Michael E. Pichichero, David I. Bernstein and Philip Hosbach and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Vaccine.

In The Last Decade

Emmanuel Vidor

29 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Vidor France 15 348 224 212 135 116 29 563
Ricardo Rüttimann United States 14 362 1.0× 98 0.4× 360 1.7× 295 2.2× 82 0.7× 36 624
James E. Froeschle United States 16 455 1.3× 384 1.7× 153 0.7× 63 0.5× 19 0.2× 26 672
M. L. Thoms United States 9 315 0.9× 99 0.4× 402 1.9× 368 2.7× 41 0.4× 9 655
Masayoshi Shinjoh Japan 16 545 1.6× 110 0.5× 280 1.3× 27 0.2× 54 0.5× 57 711
John Erlich Australia 10 226 0.6× 101 0.5× 127 0.6× 51 0.4× 33 0.3× 14 455
Agnès Hoffenbach France 12 409 1.2× 309 1.4× 117 0.6× 31 0.2× 26 0.2× 18 531
Ilse De Coster Belgium 13 231 0.7× 53 0.2× 386 1.8× 209 1.5× 39 0.3× 22 640
Anne Fiquet France 11 258 0.7× 88 0.4× 86 0.4× 17 0.1× 38 0.3× 22 357
M Santosham United States 11 170 0.5× 81 0.4× 316 1.5× 129 1.0× 80 0.7× 20 513
Mandeep Singh Dhingra United States 17 272 0.8× 225 1.0× 170 0.8× 54 0.4× 47 0.4× 55 575

Countries citing papers authored by Emmanuel Vidor

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Vidor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Vidor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Vidor more than expected).

Fields of papers citing papers by Emmanuel Vidor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Vidor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Vidor. The network helps show where Emmanuel Vidor may publish in the future.

Co-authorship network of co-authors of Emmanuel Vidor

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Vidor. A scholar is included among the top collaborators of Emmanuel Vidor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Vidor. Emmanuel Vidor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohapatra, Satyajit, Sangappa Dhaded, Sonali Kar, et al.. (2023). Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants–A randomized study. PLoS ONE. 18(8). e0284898–e0284898. 1 indexed citations
2.
3.
Choe, Young June, et al.. (2022). Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015. Infectious Diseases and Therapy. 11(4). 1479–1492. 4 indexed citations
4.
Nakayama, Tetsuo, et al.. (2020). Immunogenicity and safety of a DTaP-IPV/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan. Journal of Infection and Chemotherapy. 26(7). 651–659. 7 indexed citations
5.
Chhatwal, Jugesh, Sanjay Lalwani, & Emmanuel Vidor. (2016). Immunogenicity and safety of a liquid hexavalent vaccine in Indian infants. Indian Pediatrics. 54(1). 15–20. 19 indexed citations
6.
7.
Li, Rongcheng, Changgui Li, Yanping Li, et al.. (2015). Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China. Journal of the Pediatric Infectious Diseases Society. 5(3). 287–296. 11 indexed citations
8.
Reynolds, Donna L. & Emmanuel Vidor. (2014). Fully liquid DTaP-IPV-Hib pediatric combination vaccine (Pediacel): a review of 18 years of clinical experience. Expert Review of Vaccines. 13(8). 943–968. 4 indexed citations
9.
Vidor, Emmanuel, et al.. (2011). Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines. International Journal of Infectious Diseases. 16(2). e110–e116. 47 indexed citations
10.
11.
Rezapkin, Gennady V., А. А. Неверов, Elena Cherkasova, et al.. (2010). Repertoire of antibodies against type 1 poliovirus in human sera. Journal of Virological Methods. 169(2). 322–331. 10 indexed citations
12.
Vidor, Emmanuel & Stanley A. Plotkin. (2008). Immunogenicity of a two-component (PT&FHA) acellular pertussis vaccine in various combinations. Human Vaccines. 4(5). 328–340. 35 indexed citations
13.
14.
Mallet, E., Pascal Fabre, Paul M. Mendelman, et al.. (2000). Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants. The Pediatric Infectious Disease Journal. 19(12). 1119–1127. 46 indexed citations
15.
Vidor, Emmanuel, et al.. (1998). Comparison of Two Immunization Schedules with an Inactivated Hepatitis A Vaccine (AvaximTM). Journal of Travel Medicine. 5(4). 167–172. 9 indexed citations
16.
Zanetti, Alessandro, et al.. (1997). Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?. Journal of Hepatology. 26(1). 25–30. 20 indexed citations
17.
Vidor, Emmanuel, Carlton Meschievitz, & Stanley A. Plotkin. (1997). Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine. The Pediatric Infectious Disease Journal. 16(3). 312–322. 45 indexed citations
18.
19.
Vidor, Emmanuel, Christine Blondeau, A Goudeau, et al.. (1996). Analysis of the Antibody Response in Humans with a New Inactivated Hepatitis A Vaccine. Biologicals. 24(3). 235–242. 7 indexed citations
20.
Goilav, Christian, Jane N. Zuckerman, M Lafrenz, et al.. (1995). Immunogenicity and safety of a new inactivated hepatitis a vaccine in a comparative study. Journal of Medical Virology. 46(3). 287–292. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo Rüttimann Breakdown of academic impact, for papers by James E. Froeschle Breakdown of academic impact, for papers by M. L. Thoms Breakdown of academic impact, for papers by Masayoshi Shinjoh Breakdown of academic impact, for papers by John Erlich Breakdown of academic impact, for papers by Agnès Hoffenbach Breakdown of academic impact, for papers by Ilse De Coster Breakdown of academic impact, for papers by Anne Fiquet Breakdown of academic impact, for papers by M Santosham Breakdown of academic impact, for papers by Mandeep Singh Dhingra
Rankless by CCL
2026